Big Pharma Split Corp.
PRM.TO
TSX
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -1.48% | 289.60% | |||
| Total Revenue | -1.48% | 289.60% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -1.48% | 289.60% | |||
| SG&A Expenses | -1.54% | -1.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1.60% | 46.20% | |||
| Total Operating Expenses | -1.48% | 5.21% | |||
| Operating Income | -1.48% | 558.69% | |||
| Income Before Tax | -1.48% | 1,701.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.48% | 1,701.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.48% | 1,701.74% | |||
| EBIT | -1.48% | 558.69% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -1.49% | 1,735.54% | |||
| Normalized Basic EPS | -1.50% | 1,738.41% | |||
| EPS Diluted | -1.49% | 1,735.54% | |||
| Normalized Diluted EPS | -1.50% | 1,738.41% | |||
| Average Basic Shares Outstanding | 0.00% | -2.06% | |||
| Average Diluted Shares Outstanding | 0.00% | -2.06% | |||
| Dividend Per Share | -1.48% | 0.92% | |||
| Payout Ratio | 0.00% | 1.07% | |||
